Start
Completion

Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

Not yet recruitingRegisteredCTG

This interventional trial (n=600) will evaluate whether cognitive training can enhance or extend the rapid antidepressant effects of ketamine in patients already receiving ketamine treatment as part of their clinical care.

Details

This randomised, parallel-group trial will enrol approximately 600 patients already clinically receiving IV ketamine to test whether adjunctive web-based cognitive training versus sham training can enhance or prolong antidepressant response.

Cognitive training consists of self-administered 15–20 minute sessions via a web app delivered during the induction and post-induction phases; primary outcomes include change in depressive symptoms (MADRS) and durability of response.

Topics:Depressive Disorders

Registry

Registry linkNCT06526078